ArticleFrontiers in aging neuroscience2022
Machine Learning Models for Diagnosis of Parkinson's Disease Using Multiple Structural Magnetic Resonance Imaging Features.
Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Development and validation of radiomics models for the diagnoses of breast lesions with calcification on ultrasound.Quantitative imaging in medicine and surgery · 2026Article
- Support vector machine-driven Parkinson's disease identification: a 7-Tesla multidimensional structural MRI approach.NPJ Parkinson's disease · 2026Article
- Multimodal imaging and machine learning for diagnosis of Parkinson's disease with cognitive impairment: ASL and QSM as potential biomarkers.Frontiers in aging neuroscience · 2026Article
- Volumetric signatures of basal ganglia-thalamo-cortical and cerebello-thalamo-cortical networks in Parkinson's disease and its motor subtypes.Frontiers in aging neuroscience · 2026Article
- Applications of machine learning for computer-aided diagnosis of Parkinson's disease: progress and benchmark case study.Artificial intelligence review · 2025Article
- Sex-specific brain morphological and network differences in patients showing Parkinson's disease with and without possible rapid eye movement sleep behavior disorder.Frontiers in neurology · 2025Article
- Unlocking the potential: T1-weighed MRI as a powerful predictor of levodopa response in Parkinson's disease.Insights into imaging · 2024Article
- Machine learning models for diagnosing Alzheimer's disease using brain cortical complexity.Frontiers in aging neuroscience · 2024Article
- Long-term cognitive decline prediction based on multi-modal data using Multimodal3DSiameseNet: transfer learning from Alzheimer's disease to Parkinson's disease.International journal of computer assisted radiology and surgery · 2023Article
- Combined brain network topological metrics with machine learning algorithms to identify essential tremor.Frontiers in neuroscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to develop machine learning models for the diagnosis of Parkinson's disease (PD) using multiple structural magnetic resonance imaging (MRI) features and validate their performance. Methods: Brain structural MRI scans of 60 patients with PD and 56 normal controls (NCs) were enrolled as development dataset and 69 patients with PD and 71 NCs from Parkinson's Progression Markers Initiative (PPMI) dataset as independent test dataset. First, multiple structural MRI features were extracted from cerebellar, subcortical, and cortical regions of the brain. Then, the Pearson's correlation test and least absolute shrinkage and selection operator (LASSO) regression were used to select the most discriminating features. Finally, using logistic regression (LR) classifier with the 5-fold cross-validation scheme in the development dataset, the cerebellar, subcortical, cortical, and a combined model based on all features were constructed separately. The diagnostic performance and clinical net benefit of each model were evaluated with the receiver operating characteristic (ROC) analysis and the decision curve analysis (DCA) in both datasets. Results: After feature selection, 5 cerebellar (absolute value of left lobule crus II cortical thickness (CT) and right lobule IV volume, relative value of right lobule VIIIA CT and lobule VI/VIIIA gray matter volume), 3 subcortical (asymmetry index of caudate volume, relative value of left caudate volume, and absolute value of right lateral ventricle), and 4 cortical features (local gyrification index of right anterior circular insular sulcus and anterior agranular insula complex, local fractal dimension of right middle insular area, and CT of left supplementary and cingulate eye field) were selected as the most distinguishing features. The area under the curve (AUC) values of the cerebellar, subcortical, cortical, and combined models were 0.679, 0.555, 0.767, and 0.781, respectively, for the development dataset and 0.646, 0.632, 0.690, and 0.756, respectively, for the independent test dataset, respectively. The combined model showed higher performance than the other models (Delong's test, all p-values < 0.05). All models showed good calibration, and the DCA demonstrated that the combined model has a higher net benefit than other models. Conclusion: The combined model showed favorable diagnostic performance and clinical net benefit and had the potential to be used as a non-invasive method for the diagnosis of PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.